Indrayani Biotech Limited (BOM:526445)
India · Delayed Price · Currency is INR 10.24
+0.16 (1.59%)
At close: Oct 6, 2026
Indrayani Biotech Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 466 | 329 | 649 | 2,239 | 1,934 | 1,044 | |
Market Cap Growth | -19.69% | -49.30% | -71.00% | 15.76% | 85.28% | 380.31% |
Enterprise Value | 1,999 | 1,721 | 1,563 | 3,040 | 2,313 | 1,221 |
Last Close Price | 10.24 | 7.23 | 14.26 | 49.17 | 56.51 | 30.50 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 21.33 | 88.91 | - | 35.18 | 22.14 | 23.76 |
PS Ratio | 0.34 | 0.24 | 0.50 | 1.35 | 1.19 | 1.70 |
PB Ratio | 0.46 | 0.32 | 0.65 | 2.94 | 4.00 | 4.25 |
P/TBV Ratio | 0.94 | 0.67 | 1.32 | 5.10 | 8.61 | 5.14 |
P/FCF Ratio | 1.96 | 1.39 | - | - | - | 35.73 |
P/OCF Ratio | 1.47 | 1.04 | - | - | 11.95 | 25.39 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.45 | 1.25 | 1.20 | 1.83 | 1.42 | 1.98 |
EV/EBITDA Ratio | 20.76 | 17.87 | 24.96 | 12.43 | 12.83 | 17.76 |
EV/EBIT Ratio | 37.51 | 32.30 | 54.00 | 14.72 | 15.76 | 19.64 |
EV/FCF Ratio | 8.42 | 7.25 | - | - | - | 41.79 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 1.26 | 1.26 | 1.37 | 1.48 | 1.45 | 0.77 |
Debt / EBITDA Ratio | 13.58 | 13.32 | 21.89 | 4.60 | 3.89 | 2.73 |
Debt / FCF Ratio | - | 5.40 | - | - | - | 6.43 |
Net Debt / Equity Ratio | 1.22 | 1.22 | 1.37 | 1.08 | 1.19 | 0.68 |
Net Debt / EBITDA Ratio | 13.13 | 12.88 | 21.85 | 3.36 | 3.19 | 2.42 |
Net Debt / FCF Ratio | - | 5.22 | -16.85 | -1.76 | -10.77 | 5.69 |
Asset Turnover | - | 0.53 | 0.52 | 0.85 | 1.57 | 1.35 |
Inventory Turnover | - | 2.38 | 1.98 | 3.63 | 15.12 | 31.58 |
Quick Ratio | - | 0.68 | 0.57 | 1.08 | 0.84 | 0.90 |
Current Ratio | - | 1.71 | 1.74 | 1.67 | 1.08 | 1.01 |
Return on Equity (ROE) | - | 2.14% | -6.93% | 16.73% | 32.72% | 19.89% |
Return on Assets (ROA) | - | 1.28% | 0.72% | 6.62% | 8.85% | 8.50% |
Return on Invested Capital (ROIC) | 2.17% | 2.30% | 1.46% | 14.84% | 19.36% | 16.29% |
Return on Capital Employed (ROCE) | - | 3.30% | 1.70% | 14.10% | 17.50% | 19.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 0.79% | 1.13% | -2.40% | 2.84% | 4.52% | 4.21% |
FCF Yield | 50.93% | 72.14% | -12.50% | -20.92% | -2.76% | 2.80% |
Buyback Yield / Dilution | 33.10% | 33.10% | 74.68% | -4.74% | -27.02% | 3.86% |